Macronutrient oxidation

Macronutrient oxidation is the fundamental biological process by which carbohydrates, fats, and proteins are chemically broken down to produce energy, primarily in the form of adenosine triphosphate (ATP) [10]. This essential physiological function occurs through interconnected metabolic pathways, including glycolysis, the tricarboxylic acid (TCA) cycle, and mitochondrial oxidative phosphorylation [10, 14]. While not a discrete molecular target such as a specific receptor, it represents a primary physiological endpoint for drugs and interventions aimed at managing metabolic disorders like obesity and type 2 diabetes [8, 9]. The regulation of substrate oxidation is governed by complex hormonal signaling—primarily involving insulin and glucagon—and intracellular energy sensors like AMP-activated protein kinase (AMPK) [2, 11]. In disease states, individuals may exhibit metabolic inflexibility, an inability to switch substrate oxidation efficiently in response to nutrient availability, which contributes to insulin resistance and lipid accumulation [9, 12]. Pharmacological agents such as metformin or mitochondrial uncouplers interact with these pathways to modulate energy expenditure or shift substrate preference to improve metabolic health [2, 8]. However, therapeutic manipulation of these processes requires careful monitoring, as excessive or uncoupled oxidation can lead to severe safety issues such as hyperthermia or metabolic instability [4, 12].

Other names

Substrate oxidationEnergy metabolismCellular respirationFuel oxidationMetabolic rate

Drugs modulate the rate of macronutrient oxidation by activating intracellular energy sensors like AMPK, inducing mitochondrial uncoupling, or altering the hormonal environment to favor specific fuel utilization.